HIV-1 latency and eradication of long-term viral reservoirs
- PMID: 20350483
HIV-1 latency and eradication of long-term viral reservoirs
Abstract
HIV-1 infection is characterized by a continuous viral replication throughout the illness that can be controlled to some extent by effective treatment. Early during primary infection, latent reservoirs where the virus remains hidden in metabolically inert cells are established. These reservoirs are responsible for a low-rate viral replication that can be observed even during effective treatment and are a major obstacle for the complete eradication of the infection. This low-rate viral replication also comes from anatomical sites where drug penetration is limited and only a suboptimal drug concentration can be achieved. Further understanding of the mechanisms underlying HIV-1 latency is of primary importance to develop new strategies that ensure the complete destruction of reservoirs and, therefore, the eradication of the infection.
Similar articles
-
Ludwik Hirszfeld Memorial Lecture: HIV-1 reservoirs: major molecular obstacles to viral eradication.Arch Immunol Ther Exp (Warsz). 2004 Sep-Oct;52(5):297-306. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15507870 Review.
-
Latency: the hidden HIV-1 challenge.Retrovirology. 2006 Jan 16;3:7. doi: 10.1186/1742-4690-3-7. Retrovirology. 2006. PMID: 16412247 Free PMC article. Review.
-
[Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].Med Sci (Paris). 2010 Feb;26(2):159-63. doi: 10.1051/medsci/2010262159. Med Sci (Paris). 2010. PMID: 20188047 Review. French.
-
[Molecular basis of HIV-1 latency - Part II: HIV-1 reactivation and therapeutic implications].Med Sci (Paris). 2010 Mar;26(3):291-5. doi: 10.1051/medsci/2010263291. Med Sci (Paris). 2010. PMID: 20346279 Review. French.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
Cited by
-
A comparison of elasticities of viral levels to specific immune response mechanisms in human immunodeficiency virus infection.BMC Res Notes. 2014 Oct 20;7:737. doi: 10.1186/1756-0500-7-737. BMC Res Notes. 2014. PMID: 25331717 Free PMC article.
-
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.PLoS One. 2013 Jul 9;8(7):e68076. doi: 10.1371/journal.pone.0068076. Print 2013. PLoS One. 2013. PMID: 23874501 Free PMC article.
-
Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy.Antimicrob Agents Chemother. 2013 Jul;57(7):3110-20. doi: 10.1128/AAC.00267-13. Epub 2013 Apr 22. Antimicrob Agents Chemother. 2013. PMID: 23612193 Free PMC article.
-
Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies.Open Biol. 2020 Dec;10(12):200286. doi: 10.1098/rsob.200286. Epub 2020 Dec 23. Open Biol. 2020. PMID: 33352062 Free PMC article. Review.
-
HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim.Sci Rep. 2017 Oct 9;7(1):12866. doi: 10.1038/s41598-017-12758-w. Sci Rep. 2017. PMID: 28993666 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical